Insilico Medicine
Verified
AI-powered drug discovery platform — from target identification to clinical trials.
About Insilico Medicine
Insilico Medicine uses AI across the entire drug discovery pipeline: identifying disease targets, generating novel molecules, and predicting clinical trial outcomes. Their platform has already advanced AI-discovered drugs to human clinical trials.
Key Features
- End-to-end AI drug discovery
- Target identification with PandaOmics
- Molecule generation with Chemistry42
- Clinical trial outcome prediction
- Multiple drugs in clinical trials
Pros & Cons
Pros
+ Full pipeline AI drug discovery
+ Real drugs in clinical trials
+ Strong publication record
Cons
- Enterprise-only pricing
- Not accessible to individual researchers
- Drug discovery timelines are still long
Use Cases
Drug target identificationNovel molecule designClinical trial optimizationPharmaceutical R&D acceleration
Pricing
Enterprise
Enterprise partnerships. Research collaborations available.
Who It's For
Pharmaceutical companiesBiotech startupsDrug discovery researchersClinical research organizations
Details
More in AI Science & Healthcare